211 related articles for article (PubMed ID: 31242951)
1. A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer.
Buttarelli M; Babini G; Raspaglio G; Filippetti F; Battaglia A; Ciucci A; Ferrandina G; Petrillo M; Marino C; Mancuso M; Saran A; Villani ME; Desiderio A; D'Ambrosio C; Scaloni A; Scambia G; Gallo D
J Exp Clin Cancer Res; 2019 Jun; 38(1):279. PubMed ID: 31242951
[TBL] [Abstract][Full Text] [Related]
2. Stat1 confers sensitivity to radiation in cervical cancer cells by controlling Parp1 levels: a new perspective for Parp1 inhibition.
Raspaglio G; Buttarelli M; Filippetti F; Battaglia A; Buzzonetti A; Scambia G; Gallo D
Cell Death Dis; 2021 Oct; 12(10):933. PubMed ID: 34642300
[TBL] [Abstract][Full Text] [Related]
3. Expression of DNA damage response proteins in cervical cancer patients treated with radical chemoradiotherapy.
Ho CK; Kornaga EN; Klimowicz AC; Enwere EK; Dean M; Bebb GD; Phan T; Ghatage P; Magliocco AM; Lees-Miller SP; Doll CM
Gynecol Oncol; 2017 Apr; 145(1):176-184. PubMed ID: 28131528
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation Versus Chemoradiation for Locally Advanced Cervical Cancer: A Randomized Phase II Trial.
da Costa SCS; Bonadio RC; Gabrielli FCG; Aranha AS; Dias Genta MLN; Miranda VC; de Freitas D; Abdo Filho E; Ferreira PAO; Machado KK; Scaranti M; Carvalho HA; Estevez-Diz MDP
J Clin Oncol; 2019 Nov; 37(33):3124-3131. PubMed ID: 31449470
[TBL] [Abstract][Full Text] [Related]
5. Locally advanced cervical cancer - neoadjuvant chemotherapy followed by concurrent chemoradiation and targeted therapy as maintenance: A phase II study.
Benson R; Pathy S; Kumar L; Mathur S; Dadhwal V; Mohanti BK
J Cancer Res Ther; 2019; 15(6):1359-1364. PubMed ID: 31898673
[TBL] [Abstract][Full Text] [Related]
6. Survival outcomes of neoadjuvant chemotherapy-related strategies compared with concurrent chemoradiotherapy for locally advanced cervical cancer: a meta-analysis of randomized controlled trials.
Wang B; Tan Y; Yang X; Man X
Arch Gynecol Obstet; 2021 Aug; 304(2):485-493. PubMed ID: 33389099
[TBL] [Abstract][Full Text] [Related]
7. To study the role of pre-treatment microRNA (micro ribonucleic acid) expression as a predictor of response to chemoradiation in locally advanced carcinoma cervix.
Barik S; Mitra S; Suryavanshi M; Dewan A; Kaur I; Kumar D; Mishra M; Vishwakarma G
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1348. PubMed ID: 33660436
[TBL] [Abstract][Full Text] [Related]
8. Effect of BRCA1 on the Concurrent Chemoradiotherapy Resistance of Cervical Squamous Cell Carcinoma Based on Transcriptome Sequencing Analysis.
Wen X; Liu S; Cui M
Biomed Res Int; 2020; 2020():3598417. PubMed ID: 32685473
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer.
Choi CH; Chung JY; Chung EJ; Sears JD; Lee JW; Bae DS; Hewitt SM
BMC Cancer; 2016 Jul; 16():448. PubMed ID: 27402115
[TBL] [Abstract][Full Text] [Related]
10. PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.
Testa AC; Ferrandina G; Moro F; Pasciuto T; Moruzzi MC; De Blasis I; Mascilini F; Foti E; Autorino R; Collarino A; Gui B; Zannoni GF; Gambacorta MA; Valentini AL; Rufini V; Scambia G
Ultrasound Obstet Gynecol; 2018 May; 51(5):684-695. PubMed ID: 28620930
[TBL] [Abstract][Full Text] [Related]
11. Expression and biological function of N-myc down-regulated gene 1 in human cervical cancer.
Wang J; Cai J; Li Z; Hu S; Yu L; Xiao L; Wang Z
J Huazhong Univ Sci Technolog Med Sci; 2010 Dec; 30(6):771-6. PubMed ID: 21181370
[TBL] [Abstract][Full Text] [Related]
12. PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to assess residual tumor in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.
Testa AC; Moro F; Pasciuto T; Moruzzi MC; Di Legge A; Fuoco G; Autorino R; Collarino A; Gui B; Zannoni GF; Gambacorta A; Miccò M; Rufini V; Scambia G; Ferrandina G
Ultrasound Obstet Gynecol; 2018 Jul; 52(1):110-118. PubMed ID: 29119649
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Effects of Hemoglobin Levels Upon Tumor Response among Cervical Carcinoma Patients Undergoing Accelerated Hyperfractionated Radiotherapy versus Cisplatin Chemoradiotherapy.
Thakur P; Seam RK; Gupta MK; Rastogi M; Gupta M; Bhattacharyya T; Sharma M; Revannasiddaiah S
Asian Pac J Cancer Prev; 2015; 16(10):4285-9. PubMed ID: 26028087
[TBL] [Abstract][Full Text] [Related]
14. Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study.
Ferrandina G; Palluzzi E; Gallotta V; Gambacorta MA; Autorino R; Turco LC; Macchia G; Cosentino F; Gui B; Mattoli MV; Ronzino G; Valentini V; Scambia G
Eur J Surg Oncol; 2018 Jul; 44(7):1062-1068. PubMed ID: 29753611
[TBL] [Abstract][Full Text] [Related]
15. New Strategies for Multimodality Therapy in Treating Locally Advanced Cervix Cancer.
Verma J; Monk BJ; Wolfson AH
Semin Radiat Oncol; 2016 Oct; 26(4):344-8. PubMed ID: 27619255
[TBL] [Abstract][Full Text] [Related]
16. Identification of NDRG1-regulated genes associated with invasive potential in cervical and ovarian cancer cells.
Zhao G; Chen J; Deng Y; Gao F; Zhu J; Feng Z; Lv X; Zhao Z
Biochem Biophys Res Commun; 2011 Apr; 408(1):154-9. PubMed ID: 21463610
[TBL] [Abstract][Full Text] [Related]
17. Use of Metabolic Parameters as Prognostic Factors During Concomitant Chemoradiotherapy for Locally Advanced Cervical Cancer.
Krhili S; Muratet JP; Roche S; Pointreau Y; Yossi S; Septans AL; Denis F
Am J Clin Oncol; 2017 Jun; 40(3):250-255. PubMed ID: 27028351
[TBL] [Abstract][Full Text] [Related]
18. MAPK4 deletion enhances radiation effects and triggers synergistic lethality with simultaneous PARP1 inhibition in cervical cancer.
Tian S; Lou L; Tian M; Lu G; Tian J; Chen X
J Exp Clin Cancer Res; 2020 Jul; 39(1):143. PubMed ID: 32711558
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant carboplatin and paclitaxel after concurrent cisplatin and radiotherapy in patients with locally advanced cervical cancer.
Yavas G; Yavas C; Sen E; Oner I; Celik C; Ata O
Int J Gynecol Cancer; 2019 Jan; 29(1):42-47. PubMed ID: 30640682
[TBL] [Abstract][Full Text] [Related]
20. Chemoradiotherapy for locally advanced cervix cancer without aortic lymph node involvement: can we consider metabolic parameters of pretherapeutic FDG-PET/CT for treatment tailoring?
Voglimacci M; Gabiache E; Lusque A; Ferron G; Ducassou A; Querleu D; Motton S; Chantalat E; Courbon F; Martinez A
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1551-1559. PubMed ID: 30729273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
